Literature DB >> 9805185

Candida arthritis in an immunocompetent patient without predisposing factors.

J M Calvo Romero1, J L Alvarez Vega, J M Salazar Vallinas, R Ortega Alberdi.   

Abstract

Candida arthritis is infrequent in patients who are not intravenous drug users. We describe a patient who was not an intravenous drug user and without other predisposing factors who developed knee arthritis caused by Candida albicans. We believe that this is the first report of such a case.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9805185     DOI: 10.1007/bf01450899

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

1.  Favorable outcome with ketoconazole in Candida septic arthritis.

Authors:  S Pizarro; L Barile; A Fraga; F Medina
Journal:  J Rheumatol       Date:  1992-02       Impact factor: 4.666

2.  Coexistent septic and crystal arthritis. Report of four cases and literature review.

Authors:  P A Baer; J Tenenbaum; A G Fam; H Little
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

3.  Candida arthritis secondary to repeated intra-articular corticosteroids.

Authors:  E Ginzler; A D Meisel; M Munters; D Kaplan
Journal:  N Y State J Med       Date:  1979-03

4.  Fungal arthritis. I. Candida arthritis: diagnostic and prognostic implications and therapeutic considerations.

Authors:  A S Bayer; L B Guze
Journal:  Semin Arthritis Rheum       Date:  1978-11       Impact factor: 5.532

5.  Fungal septicemia in patients receiving parenteral hyperalimentation.

Authors:  C R Curry; P G Quie
Journal:  N Engl J Med       Date:  1971-11       Impact factor: 91.245

Review 6.  Amphotericin B: 30 years of clinical experience.

Authors:  H A Gallis; R H Drew; W W Pickard
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

Review 7.  Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature.

Authors:  E Cuende; C Barbadillo; R E-Mazzucchelli; C Isasi; A Trujillo; J L Andréu
Journal:  Semin Arthritis Rheum       Date:  1993-02       Impact factor: 5.532

8.  Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents.

Authors:  P A Robinson; A K Knirsch; J A Joseph
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

9.  A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.

Authors:  J H Rex; J E Bennett; A M Sugar; P G Pappas; C M van der Horst; J E Edwards; R G Washburn; W M Scheld; A W Karchmer; A P Dine
Journal:  N Engl J Med       Date:  1994-11-17       Impact factor: 91.245

10.  Septic arthritis in patients with acquired immunodeficiency syndrome with human immunodeficiency virus infection.

Authors:  J Rivera; I Monteagudo; J Lopez-Longo; A Sanchez-Atrio
Journal:  J Rheumatol       Date:  1992-12       Impact factor: 4.666

View more
  1 in total

1.  Candida Arthritis: Analysis of 112 Pediatric and Adult Cases.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Nikolaos V Sipsas; Brad Moriyama; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Saad J Taj-Aldeen; Andy O Miller; Ruta Petraitiene; Olivier Lortholary; Thomas J Walsh
Journal:  Open Forum Infect Dis       Date:  2015-12-23       Impact factor: 3.835

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.